A 46-year-old woman was admitted to the hospital with progressive dyspnea during minimal physical exercise (New York Heart Association class III). On admission the patient presented with tachycardia (about 110 beats per minute) and tachypnea (25 breaths per minute). She was a premenopausal, ex-smoker and she did not report any pathologic conditions in her medical history. Clinical examination revealed lower limb edema and a holosystolic murmur over the tricuspid valve, while auscultation of the lungs was normal. Blood gas analysis showed marked hypoxemia (oxygen partial pressure 51 mmHg) and hypocapnia (carbon dioxide partial pressure 29 mmHg).
Case report
A 46-year-old woman was admitted to the hospital with progressive dyspnea during minimal physical exercise (New York Heart Association class III). On admission the patient presented with tachycardia (about 110 beats per minute) and tachypnea (25 breaths per minute). She was a premenopausal, ex-smoker and she did not report any pathologic conditions in her medical history. Clinical examination revealed lower limb edema and a holosystolic murmur over the tricuspid valve, while auscultation of the lungs was normal. Blood gas analysis showed marked hypoxemia (oxygen partial pressure 51 mmHg) and hypocapnia (carbon dioxide partial pressure 29 mmHg).
The patient underwent pulmonary function testing, which revealed reduced diffusion capacity of the lung for carbon monoxide and normal ventilation. The patient's exercise capacity was low with 320 m total distance achieved in the 6-minute walk test (6MWT). Transthoracic echocardiogram excluded the presence of congenital heart disease and showed increased dimensions of the right heart chamber, while size and systolic and diastolic function of left ventricle were normal. Right ventricular systolic pressure was 78 mmHg as estimated by Doppler echocardiogram of tricuspid regurgitant velocity signal. Ventilation perfusion scanning was normal with no diffusion defects, high-resolution computed tomography (CT) excluded the presence of a parenchymal lung disease and laboratory screening of collagen or autoimmune disorders was negative, so the patient was diagnosed with severe idiopathic pulmonary hypertension (IPAH). Right heart catheterization confirmed the diagnosis showing severe hemodynamic compromise with high mean pulmonary arterial pressure at 54 mmHg, normal pulmonary capillary wedge pressure (8 mmHg), cardiac output of 3.7 L/min, cardiac index of 2.1 L/min/m 2 and pulmonary vascular resistance of 994 dyn/s/cm 5 . The patient did not report daytime sleepiness (Epworth sleepiness scale score of 9). However, the polysomnography which was performed revealed the presence of periodic breathing (PB) with severe nocturnal hypoxemia (apnea/hypopnea index (AHI) 42/h, mean SaO 2 86%, lowest SaO 2 82%, SaO 2 <90% during 72% of total sleep time). A second polysomnography was performed within 48 hours, with oxygen administration via nasal cannula at a flow of 3 L/min. Although nocturnal saturation improved, PB still persisted.
Treatment with oral anticoagulation and bosentan, a dual endothelin receptor antagonist, was initiated. At 6-month follow-up, oxygenation had improved markedly (pO 2 ¼ 61 mmHg, pCO 2 ¼ 38 mmHg); total distance during 6MWT increased to 480 m and the patient was in New York Heart Association class II. The right heart catheterization also confirmed improvement of hemodynamic parameters (mean pulmonary arterial pressure 42, cardiac output 4.8 and pulmonary vascular resistance 566 dyn/s/cm 5 ). Polysomnography was again performed with the patient breathing room air and showed complete resolution of PB (AHI 3/h, mean SaO 2 93%, lowest SaO 2 89%, SaO 2 <90% during 7% of total sleep time).
Discussion
CheyneStokes respiration is a form of PB where the period of ventilation is characterized by a prolonged waxingwaning pattern of tidal volume, followed by central apneas or hypopneas [Yumino and Bradley, 2008] . Central sleep apneas result from complete cessation of airflow for at least 10 seconds, during sleep, and are distinguished from obstructive sleep apneas by the absence of any respiratory effort [Yumino and Bradley, 2008; Kushida et al. 2005 ; American Academy of Sleep Medicine Task Force , 1999] . CheyneStokes respiration is a common sleep disorder in patients with heart failure and is associated with impaired clinical outcome and decreased survival [Javaheri et al. 2007; Lanfranchi et al. 1999] . Although data in the literature is quite limited, nocturnal PB resembling CheyneStokes has also been described among patients with pulmonary hypertension of various etiologies [Ulrich et al. 2008; Schulz et al. 2002] and it has been associated with worse quality of life [Ulrich et al. 2008 ].
The pathophysiology of CheyneStokes breathing is complex and has not yet been fully understood [Schulz et al. 2002] . It is assumed that prolonged circulation time from the lungs to chemoreceptors that stimulate breathing, due to hemodynamic impairment, play an important role [Pryor, 1951] . Furthermore, hypoxemia stimulates the peripheral chemoreceptors leading to hyperventilation [Fanfulla et al. 1998 ], while the hyperventilation-induced hypocapnia results in repeated apneas [Naughton et al. 1993 ]. In the patient that we have presented, several of these parameters were present. Low partial carbon dioxide pressure, probably below the apneic threshold, decreased partial oxygen pressure and hemodynamic compromise with reduced cardiac index could predispose to nocturnal PB, resembling CheyneStokes.
Data on the resolution of PB in patients with pulmonary hypertension are very limited. To the best of the authors' knowledge, there is only one series of 20 patients with primary pulmonary hypertension, where nasal administration of oxygen proved to be beneficial in the four out of five patients who presented nocturnal PB [Schulz et al. 2002] . There is also one report where PB completely resolved after double lung transplantation in a patient with primary pulmonary hypertension [Schulz et al. 2004 ]. However, this is the first report of a complete resolution of nocturnal PB after optimal pharmaceutical treatment of IPAH.
In conclusion, we have reported the beneficial effect of medical therapy on nocturnal PB in a patient with IPAH. Oxygen administration did not reverse the disorder. However, resolution of PB was clearly associated with hemodynamic stabilization and gas exchange improvement after optimal medical treatment for IPAH. Given the fact that PAH therapy has been recently associated with an improvement in quality of life [Tay et al. 2010; Rubenfire et al. 2009 ], the resolution of CheyneStokes respiration after pharmaceutical treatment could have a significant impact on the patient's well being.
